We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6005:TSEMiura Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

CN¥1,413.64

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kweichow Moutai is trading at CNY 1,413.64, comfortably below its 20‑day (CNY 1,448.7) and 200‑day (CNY 1,446.3) moving averages, and just under the 50‑day SMA (CNY 1,421.8). The RSI sits at 46, indicating a neutral momentum, while the MACD histogram is sharply negative, flagging bearish short‑term pressure. Volume has been trending down, and 30‑day volatility is high at roughly 34%, suggesting price swings could be sizable. Despite these technical headwinds, the market sentiment index reads “Greed” (72.9), reflecting continued investor optimism.
Fundamentally, Moutai boasts extraordinary profitability – gross margin exceeds 91%, operating margin 66% and ROE 36% – supported by strong cash generation (free cash flow > CNY 51 bn). The dividend yield of 3.65% is attractive, with a payout ratio near 72%, which appears sustainable given the cash flow profile. However, a discounted cash‑flow model values the shares at around CNY 619, far below the current price, implying the stock is markedly overvalued (PE ≈ 20×, forward PE ≈ 18×). Limited revenue growth (≈ 0.6%) and a modest beta (≈ 0.03) temper upside expectations, while regulatory and policy exposure in China adds a layer of risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD histogram and price below short‑term SMAs
  • Decreasing trading volume indicating waning momentum
  • High short‑term volatility could trigger further downside

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong cash flow and attractive dividend yield
  • Significant valuation gap between market price and DCF fair value
  • Limited revenue growth and exposure to Chinese policy shifts

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Durable brand moat and ultra‑high profit margins
  • Sustainable dividend supported by robust free cash flow
  • Exceptional ROE and low leverage provide resilience over time

Key Metrics & Analysis

Financial Health

Revenue Growth0.60%
Profit Margin50.41%
P/E Ratio19.7
ROE36.31%
ROA25.58%
Debt/Equity0.10
P/B Ratio6.9
Op. Cash FlowCN¥86.2B
Free Cash FlowCN¥51.6B

Technical Analysis

TrendNeutral
RSI46.2
SupportCN¥1,383.20
ResistanceCN¥1,568.00
MA 20CN¥1,448.69
MA 50CN¥1,421.81
MA 200CN¥1,446.29
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueCN¥618.85
GradeOvervalued
TypeBlend
Dividend Yield3.65%

Risk Assessment

Beta0.03
Volatility33.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.